The Transatlantic Trade and Investment Partnership (TTIP) will not affect the way the United Kingdom Government runs the National Health Service. It has been made clear by negotiators from both the United States and the European Union that it is up to the UK alone to decide how the NHS is run and any assertion that TTIP will undermine the Government\u2019s control of the NHS is a red herring.<\/p>
<\/p>
<\/p>
<\/p>
The TTIP could offer great benefits to British business and for British jobs. Greater consistency in existing and new regulatory requirements would make it easier for companies - especially small and medium enterprises - to access markets and, for patients, potentially help to increase access to new medicines and medical devices.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-10-21T11:09:44.1185254Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Transatlantic Trade and Investment Partnership"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what is their assessment of the implications for the National Health Service of a successful outcome to the ongoing Transatlantic Trade and Investment Partnership negotiations between the European Union and the United States.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4216", "label" : {"_value" : "Biography information for Lord Empey"} } , "tablingMemberPrinted" : [{"_value" : "Lord Empey"} ], "uin" : "HL2158"} , {"_about" : "http://data.parliament.uk/resources/93738", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/93738/answer", "answerText" : {"_value" : "
National Health Service funding has risen in each year of this parliament and is £12.7 billion higher in cash terms in 2014-15 than in 2010-11. The NHS is on track to make up to £20 billion efficiency savings this parliament to reinvest into frontline care. We are confident that it will continue to make the efficiency improvements necessary to meet rising demand and protect the quality of the services delivered.<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
In a recent report commissioned by the Department, Frontier Economics has estimated that poor care could be costing the NHS up to £2.5 billion every year. In order to focus attention on the harms contributing to these costs and the savings that could be reinvested, a poster and leaflet will go out to all NHS hospitals to display this vital information to their staff.<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
We have introduced a wide range of measures, including the Sign Up to Safety Campaign, Patient Safety Collaboratives, a new tougher inspection regime for providers and a reformed National Patient Safety Alert System to reduce mistakes in practice. In order to promote a culture of openness and transparency, that will enable organisations to learn from their mistakes, there will be the duty of candour in the event of serious harm. We are also publishing information on hospital performance, including staffing levels, as part of the new MyNHS website.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-10-21T11:10:41.7869466Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Standards"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what steps they will take to make the National Health Service more efficient and to reduce mistakes in practice.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1796", "label" : {"_value" : "Biography information for Lord Taylor of Warwick"} } , "tablingMemberPrinted" : [{"_value" : "Lord Taylor of Warwick"} ], "uin" : "HL2162"} , {"_about" : "http://data.parliament.uk/resources/93832", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/93832/answer", "answerText" : {"_value" : "
The Skipton Fund Appeals Panel has considered 412 appeals in respect of decisions made by the Skipton Fund, since the Skipton Fund was established in 2004. 210 appeals were decided in favour of the appellant and 202 were decided in favour of the Skipton Fund.<\/p>
<\/p>
<\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-21T15:53:50.5319484Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Skipton Fund"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many appeals have been made to the Skipton Fund Appeals Panel in respect of decisions made by that fund; and how many such appeals were decided in favour of (a) the appellant or (b) the Skipton Fund.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"}
}
, "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"}
, "tablingMemberPrinted" : [{"_value" : "Diana Johnson"}
], "uin" : "210937"}
, {"_about" : "http://data.parliament.uk/resources/93837", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/93837/answer", "answerText" : {"_value" : " On 24 April 2013, the independent Review of the Regulation of Cosmetic Interventions<\/em>, chaired by Sir Bruce Keogh, was published. A copy has already been placed in the Library.<\/p> <\/p> The Government Response to the Review of the Regulation of Cosmetic Interventions <\/em>was published on 13 February. A copy of the response has already been placed in the Library. We fully accept the principles of the Keogh review and the overwhelming majority of the recommendations. The response looks to protect the public through clear standards, better training and robust qualifications, and explores how far supervision from regulated professionals might support self-regulation of the sector.<\/p> <\/p> Officials are working with key delivery partners such as the Royal College of Surgeons who have set up an inter-specialty committee to ensure standards for cosmetic surgery and they are working with the General Medical Council on a code of ethical conduct. Health Education England (HEE) is leading on a review of training and qualifications for providers of non-surgical cosmetic interventions and those required to be responsible prescribers. On 11 September, HEE published a phase 1 report Review of qualifications required for delivery of non-surgical cosmetic <\/em>interventions. A copy of the report is attached. Work is also underway on a pilot breast implant registry to reassure women that if problems arise they can be contacted, kept informed and called in for treatment if necessary.<\/p> <\/p> As part of this programme of work to ensure proper training and oversight of both non-surgical and surgical cosmetic interventions, we are looking at the need for legislation to ensure public protection and will consider bringing forward proposals.<\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/93837/answer/attachment/1", "fileName" : {"_value" : "Non-surgical cosmetic interventions - Report on Phase 1 - final.pdf"}
, "title" : "Non-surgical cosmetic interventions Report"}
, "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-21T15:16:47.5194021Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Plastic Surgery"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, if he will bring forward legislative proposals to ensure that regulations regarding invasive cosmetic procedures provide the same level of protection as those concerning cosmetic surgery.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1431", "label" : {"_value" : "Biography information for Annette Brooke"}
}
, "tablingMemberConstituency" : {"_value" : "Mid Dorset and North Poole"}
, "tablingMemberPrinted" : [{"_value" : "Annette Brooke"}
], "uin" : "210880"}
, {"_about" : "http://data.parliament.uk/resources/93839", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/93839/answer", "answerText" : {"_value" : " The National Institute for Health and Care Excellence (NICE) has published clinical guidelines on a range of mental health topics, such as depression, anxiety and schizophrenia. Clinical guidelines provide guidance on the treatment of patients across the care pathway and each guideline recommends a number of treatments. <\/p> Appraisal Number<\/p><\/td> Year<\/p><\/td> Technology<\/p><\/td> Condition<\/p><\/td> Categorisation<\/p><\/td><\/tr> TA59<\/p><\/td> 2003<\/p><\/td> Electroconvulsive therapy<\/p><\/td> Catatonia/ prolonged or severe manic episode<\/p><\/td> Optimised1<\/sup><\/p><\/td><\/tr> TA098<\/p><\/td> 2006<\/p><\/td> Atomoxetine<\/p><\/td> Attention deficit hyperactivity disorder (ADHD)<\/p><\/td> Recommended<\/p><\/td><\/tr> TA098<\/p><\/td> 2006<\/p><\/td> Dexamfetamine<\/p><\/td> Attention deficit hyperactivity disorder (ADHD)<\/p><\/td> Recommended<\/p><\/td><\/tr> TA098<\/p><\/td> 2006<\/p><\/td> Methylphenidate<\/p><\/td> Attention deficit hyperactivity disorder (ADHD)<\/p><\/td> Recommended<\/p><\/td><\/tr> TA213<\/p><\/td> 2011<\/p><\/td> Aripiprazole<\/p><\/td> Schizophrenia in people aged 15-17 years<\/p><\/td> Recommended<\/p><\/td><\/tr> TA217<\/p><\/td> 2011<\/p><\/td> Donepezil<\/p><\/td> Alzheimer's disease (mild to moderate)<\/p><\/td> Recommended<\/p><\/td><\/tr> TA217<\/p><\/td> 2011<\/p><\/td> Galantamine<\/p><\/td> Alzheimer's disease (mild to moderate)<\/p><\/td> Recommended<\/p><\/td><\/tr> TA217<\/p><\/td> 2011<\/p><\/td> Rivastigmine<\/p><\/td> Alzheimer's disease (mild to moderate)<\/p><\/td> Recommended<\/p><\/td><\/tr> TA217<\/p><\/td> 2011<\/p><\/td> Memantine<\/p><\/td> Alzheimer's disease (moderate)<\/p><\/td> Optimised<\/p><\/td><\/tr> TA217<\/p><\/td> 2011<\/p><\/td> Memantine<\/p><\/td> Alzheimer's disease (severe)<\/p><\/td> Recommended<\/p><\/td><\/tr> TA292<\/p><\/td> 2013<\/p><\/td> Aripiprazole<\/p><\/td> Moderate to severe manic episodes in adolescents with bipolar disorder<\/p><\/td> Recommended<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p>
Additionally, the following technologies for the treatment of mental health and behavioural conditions are recommended by NICE technology appraisal guidance:<\/p>